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Abstract
Background: Studies of influenza vaccine effectiveness in schools have assessed all-cause absenteeism rather than
laboratory-confirmed influenza. We conducted an observational pilot study to identify absences due to respiratory illness
and laboratory-confirmed influenza in schools with and without school-based vaccination.
Methods: A local public health agency initiated school-based influenza vaccination in two Wisconsin elementary schools
during October 2010 (exposed schools); two nearby schools served as a comparison group (non-exposed schools). Absences
due to fever or cough illness were monitored for 12 weeks. During the 4 weeks of peak influenza activity, parents of absent
children with fever/cough illness were contacted and offered influenza testing.
Results: Parental consent for sharing absenteeism data was obtained for 937 (57%) of 1,640 students. Fifty-two percent and
28%, respectively, of all students in exposed and non-exposed schools were vaccinated. Absences due to fever or cough
illness were significantly lower in the exposed schools during seven of 12 surveillance weeks. Twenty-seven percent of
students at exposed schools and 39% at unexposed schools had one or more days of absence due to fever/cough illness
(p,0.0001). There was no significant difference in the proportion of students absent for other reasons (p = 0.23). During the
4 week period of influenza testing, respiratory samples were obtained for 68 (42%) of 163 episodes of absence due to fever
or cough illness. Influenza was detected in 6 students; 3 attended exposed schools.
Conclusions: Detection of laboratory-confirmed influenza in schools was challenging due to multiple consent requirements,
difficulty obtaining samples from absent children, and a mild influenza season. School-based influenza vaccination was
associated with reduced absenteeism due to fever or cough illness, but not absenteeism for other reasons. Although
nonspecific, absence due to fever or cough illness may be a useful surrogate endpoint in school-based studies if
identification of laboratory confirmed influenza is not feasible.
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Introduction
Children have high rates of influenza infection and increased
duration of viral shedding, and serve as a major source of influenza
transmission in communities [1,2]. The prevention of influenza
among children may be an effective method for reducing the
overall burden of influenza [3,4]. Routine annual influenza
vaccination of all children aged 6 months through 18 years of
age is recommended by the Advisory Committee on Immuniza-
tion Practices (ACIP) [5], and school-based vaccination campaigns
offer an opportunity to increase vaccine coverage in school-age
children [6]. However, there is limited evidence that school-based
vaccination leads to higher levels of protection against influenza in
schools compared to current practices, which require parents to
actively seek influenza vaccinations for their children [7,8].
One of the earliest studies of vaccinating school children took
place during the 1968–69 season in Tecumseh, Michigan [3].
Vaccination coverage of 86% was achieved in response to the
campaign. In the outbreak of Hong Kong influenza (A/H3N2)
that followed the campaign, rates of influenza-like illness were 3
times higher in a nearby control community compared to
Tecumseh. School absenteeism rates were also substantially lower
in Tecumseh. More recently, a county-wide vaccination program
for elementary school students in Maryland demonstrated that
absenteeism during the influenza season was reduced in the
intervention county compared to two control counties [7].
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However, reasons for absenteeism were not assessed, and
absenteeism could not be compared between vaccinated and
unvaccinated children. Similarly, King et al. examined the effect
of school-based vaccination campaigns using a controlled study
design [8]. Households with children in intervention schools
reported lower absenteeism for influenza-like illness compared to
households with children in control schools, but the change in total
absenteeism did not differ significantly between the groups. These
studies demonstrated the potential benefit of influenza vaccination
in schools, but they were not designed to estimate the direct and
indirect effects of school-based vaccination for preventing labora-
tory-confirmed influenza.
Studies involving vaccination and follow-up of children in
school settings can be resource intensive, but the potential public
health benefit is great if school-based interventions can reduce
influenza-related absenteeism and community-wide transmission.
We conducted an observational pilot study to assess the feasibility
of identifying absences due to laboratory-confirmed influenza in
vaccinated and unvaccinated students, and to compare absentee-
ism due to fever or cough illness in schools with and without the
school-based vaccination initiative.
Methods
Setting
This study was conducted in Marshfield, Wisconsin, a city with
approximately 20,000 residents in a predominantly rural area of
the state. This was an observational study of a public health
activity (school-based vaccination), and there was no research
intervention or group randomization. The Wood County Health
Department (WCHD) selected two elementary schools and the
middle school (grades 7 and 8) in the district for school vaccine
clinics out of a total of six public schools (four elementary, 1 middle
school, 1 high school) located within the city of Marshfield.
Vaccine clinics were not offered at other schools because WCHD
did not have sufficient resources to provide vaccinations at all
schools in the district. The observational study was restricted to the
elementary schools.
For the school-based vaccination program, WCHD distributed
an information letter, Vaccine Information Statement, and
consent form to parents of all children at both schools. Consenting
parents had the option to select trivalent inactivated vaccine (TIV),
live attenuated influenza vaccine (LAIV), or no preference for
vaccine type. Screening questions identified children with a
contraindication to one or both vaccines, and these children were
not eligible for vaccination. Signed consent forms were required by
WCHD at least 3 days before the scheduled school vaccination
clinic; no children were vaccinated without a signed consent form.
Parents were not required to be present at the time the child was
vaccinated. Each school was visited on two separate dates to
provide two doses when necessary and ensure that as many
students as possible were vaccinated. Vaccination clinics were held
in schools on October 5–6 and November 9–10, 2010. Parents of
children in every elementary school had access to influenza
vaccination through primary health care providers at the
Marshfield Clinic and vaccination clinics offered in other venues.
Elementary schools A and B, which held the school-based
vaccination clinics, were designated as the exposed group. The two
remaining elementary schools (C and D) located within the city of
Marshfield were designated as the non-exposed group. Total
student enrollment for the exposed and non-exposed schools was
982 and 658, respectively.
Influenza Vaccination Status
All children attending Marshfield public schools have compre-
hensive vaccination records, including influenza vaccinations, in a
web-based vaccination registry (RECIN) that is used by all private
and public vaccination providers in the area (www.recin.org) [9].
A validation study of the registry during the 2006–07 and 2007–08
influenza seasons demonstrated that the registry captured 95% of
all influenza vaccinations in the local population [10]. A
subsequent validation study during the 2010–11 influenza season
demonstrated that the registry captured 99% of all influenza
vaccinations given to children age 5–17 years old who lived in the
community (unpublished data). Children were classified as
vaccinated beginning 14 days after influenza vaccine receipt.
Children less than 9 years old were classified as fully vaccinated
only if they had received two or more lifetime doses of influenza
vaccine. Children less than 9 years of age were classified as
partially vaccinated if they had received only one of two
recommended doses.
Individual-level influenza vaccination information as of January
3, 2011 was obtained for all children whose parent(s) signed a
Family Educational Rights and Privacy Act (FERPA) consent
form. This consent was required for the school district to provide
individual student information to the investigators, including dates
of absence from school and vaccination status. Summary data on
influenza vaccination coverage was available by grade for children
attending each of the four study schools.
Enrollment and Absenteeism Surveillance
Surveillance for absenteeism due to respiratory illness and other
causes was initiated at each of the four schools on January 3, 2011,
prior to widespread circulation of influenza in central Wisconsin.
Daily surveillance of absenteeism continued for 12 weeks and
included the period of peak influenza activity. Prior to the
surveillance period, letters were sent home with students to solicit
parental FERPA consent allowing release of individual absentee-
ism data to the researchers. A second letter, which included a self-
addressed, stamped envelope, was distributed four weeks after the
initial letter in an attempt to maximize the response rate. All
families received two telephone reminders regarding the absen-
teeism consent form. Additional promotion for the study included
articles released in two consecutive quarterly school newsletters
(fall and winter 2010) and an informational booth display at each
study school during the annual open houses held prior to start of
classes each fall.
The four participating schools recorded daily all-cause absen-
teeism and absenteeism specifically due to fever or cough for the
12 week surveillance period. Individual absences (for FERPA-
consented students) and total daily absenteeism counts (for all
students) were reported by schools each day using a custom
Microsoft Access application. Training was provided to school
administrative staff who were responsible for tracking daily
absences. In some cases, parents left voice messages to indicate
student absences, and a school staff member called the parent to
determine if the absence was due to fever or cough illness or other
reasons. Only full-day absences were recorded by the schools.
Students who were sent home early due to illness were not counted
as absent on that day.
Recruitment for Influenza Testing
Due to resource constraints, influenza testing of students was
restricted to a 4-week period that included the peak of the
influenza season in central Wisconsin. Influenza testing of students
was initiated on February 7, 2011, based on increasing detection of
influenza among patients tested in the outpatient setting for a
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separate study of vaccine effectiveness [11]. Recruitment for
influenza testing was restricted to those students whose parents
had signed a FERPA consent form, which allowed daily
monitoring of school absences. The names of FERPA-consented
students who were absent due to fever or cough illness were
reported to study staff by the schools each day. Parents were then
contacted by phone by a trained research coordinator to
determine eligibility and request parental consent to collect a
swab for influenza testing. Students were eligible to participate if
their illness included fever or cough, duration from symptom onset
to enrollment was #7 days, and they had not been enrolled in the
study in the previous 14 days. Children were not eligible if they
were taking an antiviral medication (i.e., oseltamivir). Multiple
absent days due to fever or cough illness were considered a single
episode if they occurred within a 14 day window.
Nasal and throat swabs were collected from children consenting
to specimen collection. The nasal swab was collected from
children by inserting a large Dacron- or rayon-tipped swab into
one nostril to a depth of 2–3 cm, rotating gently against the
septum for 3–5 seconds and then withdrawing. The throat swab
was collected by gently wiping the posterior throat and tonsil area
with a large Dacron or rayon tipped swab. Nose and throat swabs
were combined in M4-RT viral transport media for influenza
testing. All swabs were collected at participants’ homes or in the
clinic by trained research coordinators.
This study was reviewed and approved by the Marshfield Clinic
Institutional Review Board. Written informed consent was
obtained from the parent or legal guardian of all participants
prior to specimen collection. Verbal assent for collection was
obtained from children who were at least 7 years old.
Laboratory Methods
All enrollment samples were tested for influenza using real-time
reverse transcription polymerase chain reaction (rRT-PCR).
Centers for Disease Control and Prevention (CDC) primers,
probes, and procedures were used for this assay. rRT-PCR was
performed on nucleic acid extracts using the LightCyclerH Real-
Time PCR System (Roche Diagnostics, Basel, Switzerland). Total
nucleic acid isolation and purification was performed using
automated magnetic bead technology (MagNA Pure). The rRT-
PCR assay is a TaqManH based real-time detection of the matrix
protein (M1) of influenza A and the non-structural protein 1 (NS1)
of influenza B. Both have been shown to be highly conserved,
representing effective targets for detection.
Statistical Analysis
Influenza vaccine coverage was compared for the exposed and
non-exposed schools. The weekly incidence proportion of absen-
teeism was calculated at the exposed and non-exposed schools for
two types of absenteeism: (1) absences due to fever/cough illness;
and (2) other-cause absenteeism. The incidence proportion was
calculated as the number of students absent on one or more days
in a given week (numerator) divided by the number of enrolled
students (denominator). Chi-square tests were used to assess
differences in vaccination, parental consent, and absenteeism at
the exposed and non-exposed schools. Student enrollment for
calculating absenteeism rates was based on enrollment counts as of
September 1, 2011 (1,640 students), and FERPA-consented
students were assumed to be continuously enrolled in school for
the duration of the study. Student enrollment for calculating
vaccination coverage was based on enrollment counts as of
January 3, 2011 (1,659), when vaccination data were retrieved.
The primary objective included comparison of rRT-PCR-
confirmed influenza attack rates among students attending the
exposed vs. non-exposed schools. However, few cases of labora-
tory-confirmed influenza were detected during the four week
testing period, and the primary analysis compared rates of
absenteeism due to fever or cough illness instead. The intent of
this study was to assess the feasibility of implementing a larger
study rather than hypothesis testing, and power calculations were
not performed. All statistical tests were performed in SAS 9.2
software (SAS Institute Inc., Cary, North Carolina).
Results
There were 1,640 students enrolled at the four elementary
schools as of September 1, 2010. Of these, 937 (57%) received
parental (FERPA) consent which allowed the school district to
record their individual absences for the study. The proportion of
FERPA-consented students was similar at the exposed schools
(n = 551, 56%) and the non-exposed schools (n = 386, 59%)
(p = 0.31). The majority of signed consent forms (84%) were
collected following the first distribution of the letter to parents.
Vaccination coverage for all students enrolled in the study schools
on January 3, 2011 is shown in Table 1. Fifty-two percent of all
students at the exposed schools and 28% of those attending the
non-exposed schools were fully vaccinated against influenza
(p,0.001). At the exposed schools, the school-based vaccine
clinics accounted for 65% of influenza vaccines received by
students.
Absenteeism due to fever or cough illness was significantly lower
in the exposed schools relative to the non-exposed schools during
seven of the 12 surveillance weeks. Absenteeism due to other
causes was similar at exposed and non-exposed schools with the
exception of two weeks where the non-exposed school rates were
significantly higher than the exposed school rates. The proportion
of absences due to unknown cause ranged from 0.2–1.9% per
week at the exposed schools and 0.5–2.8% at the non-exposed
schools, and accounted for 6.4% and 6.7% of all absences during
the 12 week period at the exposed and non-exposed schools,
respectively.
During the 12-week surveillance period, there was a significant
difference in the proportion of FERPA-consented students who
were absent for at least one day due to fever or cough illness at the
exposed vs. non-exposed schools (27 and 39%, respectively;
p,0.0001) (Table 2). There was no significant difference in the
proportion of FERPA-consented students with absences due to
other causes at the exposed vs. non-exposed schools (43% and
47%, respectively; p = 0.23) (Table 2). FERPA-consented students
who were unvaccinated were not more likely to be absent due to
fever or cough illness compared to students who were fully
vaccinated at either the exposed (p= 0.23) or non-exposed schools
(p = 0.41) (Table 3).
During the four week influenza testing period from February 7
to March 4, 2011, 163 episodes of absence due to fever or cough
illness (among 155 students) were recorded for FERPA-consented
students at the four schools. Eight students had two episodes of
absence due to fever or cough illness. The proportion of FERPA-
consented students with absence due to fever or cough illness
during this four week period was 17% at both the exposed and
non-exposed schools. Follow-up telephone interviews with par-
ents/guardians identified 72 illnesses that were eligible for
influenza testing. Of the remaining 91 episodes, 30 were ineligible,
38 refused to participate, and 23 were unreachable by telephone.
The most common reasons for an ineligible episode included
parent-reported absence of fever or cough illness (n = 16), language
barrier (i.e., non-English speaking parent or guardian, n = 5), and
duration of symptoms greater than seven days (n = 3). The
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explanation for the discrepancy between parent-reported and
school-reported reason for absence was not determined for the 16
children whose parents denied the presence of fever or cough
illness during a phone interview.
Consenting students were enrolled and swabbed for 68 of the 72
eligible episodes of absence due to fever/cough. Of the 68
episodes, six (9%) were rRT-PCR positive for influenza, including
3 (7%) of 46 attending exposed schools and 3 (14%) of 22
attending non-exposed schools. Of the rRT-PCR positive samples,
three were A (H3N2) and three were type B. Overall, the
proportion of FERPA-consented students with absence due to
laboratory-confirmed influenza was 0.54% at the exposed schools
and 0.77% at the non-exposed schools.
Discussion
The results from this observational study demonstrated that
school-based clinics sponsored by a local public health agency led
to increased vaccine coverage among elementary school students.
In the exposed schools, the proportion of students who received at
least one dose of vaccine was nearly two fold higher than the
proportion vaccinated at the non-exposed schools. Overall vaccine
coverage exceeded 50% at these schools, and vaccines adminis-
tered in the school clinics accounted for nearly two-thirds of all
vaccinated children at these schools. Similar levels of vaccine
coverage have been reported from school-based vaccination clinics
in other studies. In an intervention study involving 11 elementary
schools in four states, 47% of students in the intervention schools
vs. 2% in the control schools received LAIV [8]. In a
nonrandomized county-level study in Maryland, 44% of students
at 21 intervention schools received LAIV [7]. In the current study,
parents had the option to choose TIV or LAIV if there were no
contraindications, and it has been suggested that offering a choice
of vaccine may produce higher vaccination rates compared to
offering either vaccine alone [6]. Differences in parent recruitment
methods, consenting procedures, and community or school
characteristics may also influence the success of school-based
vaccination clinics.
We were able to track aggregate absenteeism (without
identifiers) due to fever/cough illness for all students, including
those without FERPA consent. Absenteeism due to fever or cough
illness was significantly reduced in exposed schools vs. non-
exposed schools. In contrast, absenteeism due to other causes (i.e.,
not fever or cough) was similar at the exposed and non-exposed
schools. These findings suggest that absenteeism due to fever or
cough illness during periods of influenza circulation may be a
useful endpoint to monitor in larger school-based studies when
influenza diagnostic testing is not feasible. However, absenteeism is
a nonspecific outcome and more susceptible to bias and
confounding compared to rRT-PCR confirmed influenza. Unfor-
tunately, we were unable to compare absenteeism due to fever or
cough illness in the schools during periods when influenza was not
circulating, since the schools did not record the reason for absence
prior to initiation of the study.
Identifying absences due to rRT-PCR confirmed influenza was
challenging due to lack of FERPA consent for many students,
difficulty contacting parents, and the occurrence of a relatively
mild influenza season. We had anticipated a high level of parental
FERPA consent to monitor absenteeism, which would allow us to
contact parents by phone and offer influenza testing whenever a
child was absent with an illness that included fever or cough. We
actively recruited and informed parents through a variety of
methods, including letters sent home with students, attendance at
school open houses, and automated telephone reminders. Despite
Table 1. Influenza vaccination status for students with and without FERPA consent to monitor absences.
Influenza Vaccination
status Exposed schools Non-exposed schools All Schools
Consented*
Non-
consented Total Consented* Non-consented Total
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Fully vaccinated 350 (63.5) 171 (38.2) 521 (52.2) 124 (32.1) 58 (21.2) 182 (27.6) 703 (42.4)
Partially vaccinated 39 (7.1) 34 (7.6) 73 (7.3) 35 (9.1) 25 (9.1) 60 (9.1) 133 (8.0)
Not vaccinated 162 (29.4) 243 (54.2) 405 (40.5) 227 (58.8) 191 (69.7) 418 (63.3) 823 (49.6)
Total 551 448 999 386 274 660 1659
*students with parental FERPA consent.
Vaccination status and enrollment was determined as of January 3, 2011.
doi:10.1371/journal.pone.0072243.t001
Table 2. Association between school type and absenteeism among FERPA-consented students.
Absent due to fever or cough illness Absent due to other causes
Exposed Schools
Non-exposed
Schools
Odds Ratio
(95% CI) Exposed Schools
Non-exposed
Schools
Odds Ratio (95%
CI)
No. (%) No. (%) No. (%) No. (%)
Absent $1 day 146 (26.5) 150 (38.9) 1.76 (1.33, 2.33)
p,0.0001
235 (42.7) 180 (46.6) 1.18 (0.9, 1.53)
p = 0.23
Never absent 405 (73.5) 236 (61.1) 316 (57.4) 206 (53.4)
doi:10.1371/journal.pone.0072243.t002
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these efforts, over 40% of students did not have parental consent to
monitor individual absenteeism, although the proportion consent-
ing was similar at the exposed and non-exposed schools. In the
absence of parental consent, a large proportion of students could
not be identified or offered influenza testing if they were absent
due to fever or cough. Comments from teachers suggested that
some parents at the exposed schools were confused by receipt of
multiple consent forms, including a vaccination consent from the
local health department, and a FERPA consent form from
Marshfield Clinic for monitoring absenteeism. Some parents
reportedly believed that completion of one form gave permission
for participation in both activities. However, this did not account
for the low proportion consenting at the non-exposed schools
where vaccine clinics were not held.
An additional limitation was that students with parental FERPA
consent represented a biased sample of all students attending these
schools. The consented students at both the exposed and non-
exposed schools had higher influenza vaccine coverage compared
to their non-consented counterparts, and absenteeism due to other
causes (i.e., not fever or cough) was higher among non-consented
students. Absenteeism due to fever or cough illness was similar
among consented and non-consented students at the exposed
schools, but not at the non-exposed schools. The reason for this
difference is not apparent. The requirement for FERPA consent
was directly related to the study goal of identifying cases of rRT-
PCR confirmed influenza among students absent with fever or
cough. Eliminating any contact with individual students and
parents would have avoided the need for FERPA consent because
personal identifiers would not have been needed. For example, a
recent study of A (H1N1)pdm09 monovalent vaccine administra-
tion in Maine elementary schools used school absenteeism as the
endpoint without utilizing individual-level data [12]. However,
assessment of all-cause absenteeism can lead to substantial
outcome misclassification and underestimation of vaccine effects
relative to a specific endpoint such as rRT-PCR confirmed
influenza.
Our experience with this pilot study suggests that larger school-
based studies using rRT-PCR confirmed influenza as the primary
endpoint may be difficult to implement and resource intensive.
One study addressed this challenge during the 2009 pandemic by
using a case-control design with influenza cases identified through
clinical rRT-PCR testing and laboratory-based reporting [13].
Controls were sampled from classmates without influenza-like
illness who were present in school. Such a design can be useful to
estimate direct vaccine effects, but the indirect and combined
effects of school-based vaccination cannot be assessed. Although
the optimal study design remains uncertain, further evaluation of
school-based influenza vaccination is needed to determine its
impact at the individual, school and community level.
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